1Kladney RD, Bulla GA, Guo L, et al. GP73, a novel Golgi- localized protein upregulated by viral infection. Gene, 2000, 249 : 53-65.
2Wei S, Dunn TA, Isaacs WB, et al. GOLPH2 and MYO6: putative prostate cancer markers localized to Golgi apparatus. Prostate, 2008, 68: 1387-1395.
3Wright LM, Huster D, Lutsenko S, et al. Hepatocyte GP73 expression in Wilson disease. J Hepatol, 2009, 51:557 564.
4Kladney RD, Tollefson AE, Wold WS, et al. Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain. Virology, 2002, 301:236 246.
5Iftikhar R, Kladney RD, Havlioglu N, et al. Disease-and cell- specific expression of GP73 in human liver disease. Am J Gastroenterol, 2004, 99: 10,g7-1095.
6Bachert C, Fimmel C, Linstedt AD. Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic, 2007,8= 1415q423.
7Kladney RD, Cui X, Bulla GA, et al. Expression o{ GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology, 2002, 35= 1431-1440.
8Maitra A, Thuluvath PJ. GP73 and liver disease: a(Golgi) complex enigma. Am J Gastroenterol, 2004, 99= 1096-1098.
9Block TM, Comunale MA, Lowman M, et al. Use of targeted glycoproteomics to identify serum glyeoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sei USA, 2005, 102:779 784.
10Schwegler EE, Cazares L, Steel LF, et al. SELDI TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology, 2005, 41: 634 642.
4Cassandra Willyard. Researchers look for ‘sweet' method to diagnose cancer. Nat Med, 2007, 13: 1267.
5Kladney RD, Bulla GA, Guo L, et al. GP73, a novel golgilocalized protein upregulated by viral infection. Gene, 2000, 249 : 53-65.
6Kladney RD, Cui X, Bulla GA, et al. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology, 2002, 35 : 1431-1440.
7Marrero JA, Romano PR, Nikolaeva O, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol, 2005, 43: 1007-1012.
8Gu Y, Chen W, Zhao Y, et al. Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases [ J ]. Ann Clin Biochem, 2009,46( Pt 1 ) :38-43.
9Baehert C, Fimmel C, Linstedt AD. Endosomal trafficking and proprotein convertase cleavage of eis Golgi protein GP73 produces marker for hepatocellular carcinoma[ J]. Traffic, 2007, 8 (10) : 1415-1423.
10Kladney RD, Bulla GA, Guo L, et al. GP73, a novel Golgi-loealized protein upregulated by viral infection[J]. Gene, 2000, 249(1-2) :53- 65.
1Benowita S. Liver cancer biomarkers struggling to succeed[ J]. J Natl Cancer Inst, 2007,99:590-591.
2Ming-Chen Ba, Hni Long, Yun-Qiang Tang, et al. GI773 expression and its significance in the diagnosis of hepatocellular carcinoma: a review [J]. Int J Clin Exp Pathol,2012,5(9) :874-881.
3Ozkan H, Erdal H, Tutkak H, et al. Diagnostic and prognostic validi- ty of Golgi Protein 73 in hepatocellular carcinoma [ J ]. Digestion, 2011,83:83-88.
4Gu Y, Chen W, Zhao Y, et al. Quantitative analysis of elevated serum Golgi protein73 expression in patients with liver diseases[ J]. Ann Clin Bioehem ,2009,46:38-43.
5Marrero JA, Romano PR, Nikolacva O, et al. GP73, a resident Golgi glyeoprotein, is a novel serum marker for hepatocellular carcinoma [ J ]. J Hepato1,2005,43 : 1007-1012.
